Dr Ravindra Rao

2. Designation: Professor

3. Qualifications: MD (Psychiatry)

4. Email ID: This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it.

5. Field of interest: community-based treatment; harm reduction; opioid agonist treatment; Consultation-Liaison-Addiction-Psychiatry

6. Speciality clinics: Community clinic (Sundernagari); Consultation-Liaison-Addiction-Psychiatry

7. Total number of publications till date: 78

8. Details of publications since 2010 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications) (Last 10 years) JOURNAL ARTICLES

1. Patel V, Rao R, Bhad R, Mishra AK, Quraishi R, Gupta Y. Prevalence & predictors of sexual functioning & sex hormone profiles among men with opioid dependence: A community- based, cross-sectional study. Indian J Med Res, 2025;162:754-763

2. Sabir Md, Rao R, Mishra AK, Bhargava R, Ambekar A. Comparative Study of Delay Discounting Rates in Alcohol and Opioid Dependence in Northern India. Indian Journal of Community Medicine;2026. DOI: 10.4103/ijcm.ijcm_344_24

3. Dhawan A, Chatterjee B, Bhargava R, Chopra A, Mandal P, Rao R, Ambekar A, Mishra A, Agrawal A, Bhuyan D, Khess CJR, Sidana A, Dalal P, Kandasamy A, Shankar U, Lenin Singh RK, Parkar S, Khan AW. Substance use among school-going adolescents in India: Results from a nationwide survey. Natl Med J India 2025;38:332–8. DOI: 10.25259/NMJI_824_2022

4. Patel V, Harsha, Kumar A, Quraishi R, Rao R. Intravenous Non-medical Mephentermine Use Among Young Men: A Consecutive Case Series from a Tertiary Addiction Facility in India. Asian Journal of Psychiatry, 2025. DOI: 10.1016/j.ajp.2025.104525

5. Quraishi R, Kumar R, Sarkar S, Rao R, Ambekar A. Gene polymorphism Mu opioid receptor & its impact on naltrexone treatment response in alcohol-dependent individuals: A pilot study from north India. The Indian Journal of Medical Research 2025. 161:1-3. DOI: 10.25259/IJMR_141_2024

6. Patel V, Harsha, Kumar A, Quraishi R, Rao R. Non-medical mephentermine use: A systematic review of literature. Journal of Addiction Medicine 2025. DOI: 10.1097/ADM.0000000000001485

7. Singh YC, Singh S, Bhad R, Rao R. Buprenorphine ‘microdosing’ method for switching patients with opioid dependence from methadone to buprenorphine. BMJ Case Rep 2024;17:e259716. doi:10.1136/bcr-2024-259716

8. Bhad R, Deepak MB, Patel V, Jangra J, Shakya P, Rao R. A community-based telemedication-assisted treatment (TMAT) for delivery of methadone maintenance treatment (MMT) during the COVID-19 pandemic in India: A single-arm, prospective feasibility study. Heroin Addiction Related Clinical Problem, 2024; 26,26 DOI: 10.62401/2531-4122-2024-26

9. Kumar R, Quraishi R, Sarkar S, Rao R, Ambekar A. Naltrexone and its effect on craving and alcohol use among patients with alcohol dependence syndrome: A report. Addiction and Health. 2024,16(3):224-227. DOI: 10.34172/ahj.1494

10. Singh V, Kaloiya G, Ambekar A, Rao R, Mishra A. Effectiveness of Family Intervention Addressing Expressed Emotions in Recipients of Opioid Substitution Therapy: A Randomised Controlled Study. Drug and Alcohol Dependence 2024. 260:110426. DOI: 10.1016/j.drugalcdep.2023.110426

11. Shakya P, Jangra J, Rao R, Mishra AK, Bhad R. Assessment of treatment retention rates and predictors of retention on opioid agonist treatment among adolescents. Drug and Alcohol Review, 2024; DOI: 10.1111/dar.13890

12. Das S, Sarkar S, Bhowmik K, Mukherjee S, Saha I, Basu A, et al. Perceptions on Treatment Utilization and Risk of Overdose Among Opioid Users in Kolkata: A Qualitative Study. Indian Journal of Psychological Medicine, 2024. DOI: 10.1177/02537176241259144

13. Shakya P, Rao R, Agrawal A, Bhad R, Ambekar A, Yadav D. Are people with opioid dependence who inject opioids different from those who do not? – Findings from a cross‑sectional, observational, community‑based study from North India. Indian J Soc Psychiatry 2024;40:21-9.

14. Rao R, Ganesh R, Kishore K, Madan I, Khandpal B, Sharma C. Pattern and characteristics of Amphetamine Type Stimulant use in a north-eastern state of India: A cross-sectional study. Indian Journal of Psychological Medicine, 2024. Apr 4:02537176241236899. doi: 10.1177/02537176241236899

15. Kathiresan P, Patel V, Jangra J, Chattopadhyay A, Abdus S, Jadhav M, Rao R, Arya A, Bansal PD, Chinggouman C, Bhad R, Ambekar A, Agrawal A, Chatterjee B, Yadav D. Experience of patients on methadone maintenance treatment receiving take-home methadone doses during COVID-19 pandemic: A multi-site study from India. Asian Journal of Psychiatry, 2024. DOI: 10.1016/j.ajp.2024.103979

16. Gupta A, MB Deepak, Rao Ravindra, Bhad R. COVID-19 acceptability in patients with opioid dependence – a cross-sectional, community-based study. Journal of Substance Use, 2023. DOI 10.1080/14659891.2023.2261046

17. Goyal P, Kattula D, Rao R, Bhad R, Mishra AKM, Dhawan A. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo controlled-trial. Drug and Alcohol Dependence, 2023. DOI 10.1016/j.drugalcdep.2023.110891

18. Ghosh S, Jain R, Rao R, Mishra AK, Jhanjee S. Does ethyl glucuronide in hair correlates with alcohol consumption? A comparative study with other traditional biomarkers among individuals with alcohol dependence syndrome. Alcohol, Nov 2022. https://doi.org/10.1016/j.alcohol.2022.10.005

19. Rao R, Chadda R, Kathiresan P, Gupta R, Bhad R, Mishra AK, Deb KS, Rajhans P, Ganesh R. Prevalence of substance use and substance use disorder in medically ill patients: A cross-sectional, hospital-based study from India. National Medical Journal of India, 2022. (Accepted for publication)

20. Kainth D, Kathiresan P, Bhad R, Rao R, Verma A. A Hyperalert Newborn. Neoreviews, 2022;23(6):e413-415

21. Quraishi R, Varshney M, Rao R, Ambekar A. Evaluation of alcohol use pattern among OST patients using alcohol biomarkers: Report from community clinics in India. Indian Journal of Psychiatry, 2022;64(3):312-15

22. Rao R, Kathiresan P, Kishore K, Kumar P, Sharma C, Mishra JK. Physical and mental health of women whose spouses inject drugs – A cross-sectional, multi-site study. Indian Journal of Public Health, 2022;66(1):57-60

23. Quraishi R, Kathiresan P, Verma K, Rao R, Jain R. Effect of chronic opioid use on the hematological and inflammatory markers: A retrospective study from North India. Indian Journal of Psychiatry, 2022;64(3):252-256

24. Saini R, Parmar A, Rao R, Mishra AK, Ambekar A, Agrawal A. Psychiatric and substance use comorbidities among people who inject drugs in India: A cross-sectional, community-based study. World Soc Psychiatry 2021;3:195-202

25. Garcia RR, Keeley J, Vega-Ramirez H, Cruz-Islas et al. Validity of Categories Related to Gender Identity in ICD-11 and DSM-5 Among Transgender Individuals who Seek Gender-Affirming Medical Procedures. International Journal of Clinical and Health Psychology 2021. DOI: 10.1016/j.ijchp.2021.100281

26. Mathur R, Parmar A, Singh S, Tandup T, Bhad R, Rao R. Sildenafil misuse for its psychoactive properties? A case report. Journal of Addiction Medicine 2021; 15(6):522-524

27. Singh B, Rao R. Is there an opioid epidemic in India? Journal of Public Health, 2021;43 (Suppl 2). https://doi.org/10.1093/pubmed/fdab322

28. Ganesh R, Rao R, Deb KS, Bhad R, Yadav D. Digital Capacity and Interest in mHealth Interventions Among Individuals on Opioid Agonist Maintenance Treatment: A Cross-Sectional Community-Based Study. Indian Journal of Psychological Medicine. July 2021. https://doi:10.1177/02537176211027239

29. Ghosh S, Jain R, Singh S, Rao R, Mishra AK, Jhanjee S. A simplified approach for determination of urinary ethyl glucuronide by gas chromatography–mass spectrometry. Journal of Analytic Science and Technology, 2021;12:35. https://doi.org/10.1186/s40543-021-00290-6

30. Singh A, Rao R, Chatterjee B, Mishra AK, Kaloiya G, Ambekar A. Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study. Asian Journal of Psychiatry, 2021. https://doi.org/10.1016/j.ajp.2021.102697

31. Rao R, Dhawan A, Parmar A, Yadav D, Bhad R. Improving Treatment of Substance Use Disorders through Community Drug Treatment Clinics: An Experiential Account. Indian Journal of Community Medicine, 2021; 46(3):370-3

32. Rao R, Yadav D, Bhad R, Rajhans P. Mobile Methadone Dispensing – Experience of a new model of methadone delivery from India: An Implementation Research. Bulletin of the World Health Organization, 2021;99:422–28 doi: http://dx.doi.org/10.2471/BLT.20.251983

33. Kathiresan P, Bhad R, Rao R. What’s in a name? Nosological issues in substance use and addictive disorders: perspectives form ICD-11. Asian J Psychiatry. 2021, Feb 10;57: 102585.

34. Sartaj D, Krishnan V, Rao R, Ambekar A, Dhingra N, Sharan P. Mental illnesses and related vulnerabilities in the Hijra community: a cross-sectional study from India. International Journal of Social Psychiatry, 2020. Aug 20:20764020950775. 

35. Kathiresan P, Rao R, Narnoli S, Hans G, Sharan P. Adjuvant Trazodone for management of Protracted Delirium Tremens. Indian Journal of Psychological Medicine, 2020. https://doi.org/10.1177/0253717620933436

36. Dhagudu NK, Ambekar A, Agrawal A, Rao R, Mishra AK, Jain R, Singh S. Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects. Drug and Alcohol Review, 2020. (doi.org/10.1111/dar.13057)

37. Rao R, Gupta SK, Ramshankar P, Gupta V, Dhawan A, Agrawal A, Ambekar A. Predictors of long-term retention on opioid agonist treatment with buprenorphine: a six-year, community-based retrospective cohort study in India. Journal of Substance Use, 2020. DOI: 10.1080/14659891.2020.1736666

38. Rao R, Panda U, Gupta SK, Ambekar A, Gupta S, Agrawal A. Portrayal of alcohol in Bollywood movies: A mixed methods study. Indian Journal of Psychiatry, 2020; 62(2):159-166. DOI: 10.4103/psychiatry.IndianJPsychiatry_294_19

39. Gupta S, Lal R, Rao R, Mishra AK, Ambekar A. The Pattern of Alcohol Use and Its Relationship with Consequences Among Problem Alcohol Users: A Community Based Cross-Sectional Study from India. Indian Journal of Psychiatry, 2020; 62(2):152-158. DOI: 10.4103/psychiatry.IndianJPsychiatry_194_19

40. Kathiresan P, Rao R, Joshi T, Bhad R, Bhatnagar S, Deb KS, Chadda RK. Chronic non-cancer pain and opioid addiction – diagnostic and management challenges. Indian Journal of Palliative Care, 2020. 26(4):544-547

41. Saini R, Rao R, Parmar A, Mishra AK, Ambekar A, Agrawal A, Dhingra N. Rates, knowledge and risk factors of non-fatal opioid overdose among People Who Inject Drugs in India: A community-based study. Drug and Alcohol Review. 2020 Jan;39(1):93-97. doi: 10.1111/dar.13016.

42. Dhagudu N, Gupta S, Bhad R, Rao R. Community‑based Management of Opioid Use Disorder: Role of Nursing Professionals and Paramedical Workers. Indian J Psy Nsg 2019; 16:43-8

43. Tripathi R, Rao R, Dhawan A, Jain R, Sinha S. Opioid and Sleep – A Review of Literature. Sleep Medicine, 2020 Mar;67:269-275. doi: 10.1016/j.sleep.2019.06.012.

44. Tripathi R, Dhawan A, Rao R, Mishra AK, Jain R, Sinha S. Assessment of subjective sleep problems in males with opioid dependence maintained on buprenorphine. Journal of Addiction Medicine, 2019. doi: 10.1097/ADM.0000000000000539

45. Rao R, Varshney M, Singh S, Agrawal A, Ambekar A. Mental Healthcare Act, 2017 and Addiction Treatment: Potential Pitfalls and Trepidations. Indian Journal of Psychiatry, 2019;61:208-12. DOI: 10.4103/psychiatry.IndianJPsychiatry_463_18

46. Quraishi R, Varshney M, Singh A, Singh D, Kumar M, Rao R, Jain R, Ambekar A. Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study. Indian J Psychol Med 2019;Nov 11;41(6):529-534.

47. Modak T, Bhad R, Rao R. A rare case of physical dependence with psychedelic LSD – A case Report. J Subst Use. 2019. DOI: 10.1080/14659891.2019.1581286

48. Ghosh S, Jain R, Jhanjee S, Rao R, Mishra AK. Alcohol Biomarkers and their Relevance in Detection of Alcohol Consumption in Clinical Settings. International Archives of Substance Abuse and Rehabilitation,2019;1:1-8

49. Ambekar A, Rao R, Agrawal A, Kathiresan P. Research on Opioid Substitution Therapy in India: a brief, narrative review. Indian Journal of Psychiatry, 2018;60(3):265-70

50. Modak T, Bhad R, Rao R. Utility of Aripiprazole in co-occurring problem gambling and toluene dependence: A case report. Journal of Substance Use 2019;24:117-19 DOI: 10.1080/14659891.2018.1523964

51. Singh J, Gupta R, Prajapati DC, Rao R. Use of opium containing herbal drug and associated mania. Asian Journal of Psychiatry (2018). 36, 36-37

52. Bagra I, Krishnan V, Rao R, Agrawal A. Does cannabis use influence opioid-related outcomes and quality of life among buprenorphine-maintained patients? - a cross-sectional, comparative study. Journal of Addiction Medicine (2018); 12(4):315-320. DOI: 10.1097/ADM.0000000000000406.

53. Parmar A, Patil V, Sarkar S, Rao R. An observational study of treatment seeking users of natural opiates from India. Substance Use and Misuse, 2017, Dec 8:1-7. DOI: 10.1080/10826084.2017.1400564.

54. Gupta S, Lal R, Rao R, Mishra AK, Ambekar A. Pattern of alcohol use among problem alcohol users in a community-based setting in India: A cross-sectional study. Journal of Substance Use, 2017: 130-135. DOI: 10.1080/14659891.2017.1366557

55. Dhawan A, Rao R, Ambekar A, Pusp A, Ray R. Treatment of Substance Use Disorders through the Government Health facilities: Developments in the ‘Drug De-Addiction Programme’ of Ministry of Health and Family Welfare, Government of India. Indian Journal of Psychiatry, 2017;59(3):380-84

56. Rajhans P, Rao R. Book review: Demons: Our changing attitudes to alcohol, tobacco, & drugs. National Medical Journal of India, 2017;30(3):174-75

57. Rao R. The Journey of Opioid Substitution Therapy in India: Achievements and Challenges. Indian Journal of Psychiatry, 2017; 59(1): 39-45.

58. Patil V, Tewari A, Rao R. New Psychoactive Substances: Issues and Challenges. J Mental Health Hum Behav 2016;21(2):98-104

59. Rao R, Ambekar A, Agrawal A, Pawar AKS, Mishra A, Khandelwal SK. Evaluation of a five-day training programme on Opioid Substitution Therapy in India, 2016. Drugs: Education, Prevention & Policy. DOI: 10.3109/09687637.2016.1167166

60. Rao R, Mandal P, Gupta R, Ramashankar P, Mishra AK, Ambekar A, Jhanjee S, Dhawan A. Factors affecting drug use during incarceration: a cross-sectional study of opioid-dependent persons from India. Journal of Substance Abuse Treatment, 2015 DOI: 10.1016/j.jsat.2015.08.009

61. Kuppuli PP, Bhad R, Rao R, Dayal P, Ambekar A. The mis-adventurous use of prescription opioids in chronic non-cancer pain: a case report. The National Medical Journal of India, 2015, 28(6):284-85.

62. Varshney M, Ambekar R, Lal R, Yadav D, Rao R, Mishra A. Brief interventions for harmful alcohol use in opioid-dependent patients on maintenance treatment with buprenorphine: a prospective study from India. Addictive Disorders and their Treatment, 2015. DOI: 10.1097/ADT.0000000000000076

63. Ambekar A, Rao R, Agrawal A, Goyal S, Mishra A, Kishore K, Mukherjee D, Albertin C. Pattern of Drug Use and Associated Behaviors Among Female Injecting Drug Users From Northeast India: A Multi-Centric, Cross-Sectional, Comparative Study. Substance Use and Misuse, 2015, 50(10): 1332-1340. DOI: 10.3109/10826084.2015.1013130

64. Ambekar A, Rao R, Mishra AK, Agrawal A. Types of Opioids injected – Does it matter? A multi-centric cross-sectional study of people who inject drugs. Drug and Alcohol Review, 2015, 34: 97-104

 BOOKS/MANUALS/REPORTS

1. Patel V, Rao R. Neither Panacea nor Poison: The Psychedelics and Psychiatry Tango. APSI Newbuzz, the official newsletter of Addiction Psychiatry Society of India, 2025, 3(3). New Delhi: APSI. ISSN 2584-2730 (Online).

2. Patel V, Rao R. Navigating the Dual Challenge: Substance Use and Pregnancy. APSI Newbuzz, the official newsletter of Addiction Psychiatry Society of India, 2025, 3(2). New Delhi: APSI. ISSN 2584-2730 (Online).

3. Patel V, Rao R. Between Relief and Risk: Rethinking Opioid Use in Chronic Non-Cancer Pain. APSI Newbuzz, the official newsletter of Addiction Psychiatry Society of India, 2025, 3(1). New Delhi: APSI. ISSN 2584-2730 (Online).

4. Rao R, Kathiresan P (Eds). Understanding the phenomenon of chemsex. APSI Newbuzz, the official newsletter of Addiction Psychiatry Society of India, 2024, 2(1). New Delhi: APSI. ISSN 2584-2730 (Online).

5. Chadda RK, Jain R, Lal R, Rao R, Quraishi R, Garg PD, Bala N, Singh RKL, Padhy S, Basu A, Krishnan V. Detection of new psychoactive substances among substance abuse treatment seekers in India – multi-centric study. Department of Revenue, Ministry of Finance, Government of India, New Delhi 2023

6. Rao R. One stop integrated model for women who use drugs in Punjab: An Implementation Document. Alliance India, New Delhi, 2020

7. Rao R, Kathiresan P. Assessment of Standards of Care in Services for People Who Use Drugs in India. Alliance India, 2020.

8. Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda R on behalf of the group of investigators for the National Survey on Extent and Pattern of Substance Use in India (2019). Magnitude of Substance Use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India.

9. Rao R, Ambekar A, Agrawal A. Opioid Substitution Therapy under National AIDS Control Programme: Clinical Practice Guidelines for treatment with Methadone. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, 2017

10. Ambekar A, Rao R, Agrawal A, Varshney M. Methadone Maintenance Treatment under National AIDS Control Programme: Training Manual. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, 2016

11. Rao R, Arumugam V, Sharma C, Beddoe S, Peters T, Mehta A, Robertson J. Community Action on Harm Reduction in India: Impact Assessment, India HIV/AIDS Alliance, 2015

12. Ambekar, A., Kumar, R., Rao, R., Agrawal, A., Kumar, M., & Mishra, A. K. (2015). Punjab Opioid Dependence Survey. Retrieved from http://pbhealth.gov.in/scan0003%20(2).pdf

9. Presentations made at scientific meetings/ conferences/ workshops

10. Funded projects 

1. Principal Investigator/Co-PI in funded projects title along with year completed/ongoing

• Assessment of rates and causes of mortality among people with opioid dependence: a longitudinal, cohort study. Supported by Indian Council of Medical Research, Ministry of Health and Family Welfare, Govt. of India

• Assessment of HIV, other Blood-borne Viruses, TB and Risk Behaviours among Prison Inmates in Gujarat. Supported by UNODC, Regional Office for South Asia

• Rates and Pattern of Psychoactive Substance Use among Prison Inmates in India: Supported by Ministry of Social Justice and Empowerment, Govt. of India

• Developing and testing an online training programme for medical officers on treatment of substance use disorders: Supported by Ministry of Social Justice and Empowerment, Govt. of India

• Assessment of pattern and trends of Amphetamine type Stimulants use in Manipur and Mizoram: a cross-sectional, multi-site study. Supported by Alliance, India

• Assessment of HIV-related risk behaviours and vulnerabilities among female spouse of male injecting drug users in Delhi – a cross-sectional, observational study. Supported by Alliance, India

• Rates of non-fatal opioid overdose among people who inject drugs in Delhi: A cross-sectional study. Supported by Alliance, India

• Portrayal of psychoactive substance use in Bollywood movies: a mixed methods study: supported by AIIMS, New Delhi

B. Co-investigator in funded projects title along with year completed/ongoing

National Survey to estimate extent and pattern of substance use in India: supported by Ministry of Social Justice and Empowerment, 2025 – ongoing

• Field Testing of the International Standards for the Treatment Drug Use Disorders (The Standards) in India

• Service -based field testing of ICD-11: Public Health/Clinical Utility and Comparability with ICD-10 in India

• Detection of New Psychoactive Substances among Substance Abuse Treatment Seekers in India: A multi-centric Study: Supported by the National Fund for Control of Drug Abuse (NFCDA), Department of Revenue, Ministry of Finance, Government of India.

• Developing and Implementing Training Mechanism for use of Essential Narcotic Drugs (ENDs) for treatment of Opioid Dependence: Supported by the National Fund for Control of Drug Abuse (NFCDA), Department of Revenue, Ministry of Finance, Government of India.

• National Survey to estimate extent and pattern of substance use in India: supported by Ministry of Social Justice and Empowerment 2016 – 2019

• Developing and testing an online training programme on implementing opioid substitution therapy: supported by Public Health Foundation of India

• Size estimation of Drug Dependent Population in the state of Punjab: supported by Ministry of Social Justice and Empowerment

• Methadone Maintenance Treatment in India: a multi-site feasibility and effectiveness study: supported by UNODC, Regional office for South Asia, New Delhi

• Post Marketing Surveillance of Methadone: supported by Rusan Pharmaceuticals, India

• National Technical Training Centre: Supported by Global Fund to Fight AIDS, Tuberculosis and Malaria-Round 9, HIV-IDU project

• Assessment of Pattern of Drug Use, among Clients receiving services from IDU Targeted Interventions (TIs) in Bihar, Haryana and Uttarakhand: Supported by India HIV/AIDS Alliance for National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India)

11. Non funded projects A. Principal Investigator/Co-PI in non-funded projects title along with year completed and ongoingB. Co- investigator in non-funded projects title along with year completed and ongoing

12. Thesis supervised for MD/ PhD

- As guide (number only) 6- As co-guide (number only) 13

13. Significant events/achievements/awards

• Awarded AIIMS EXCELLENCE RESEARCH AWARD, 2021 for outstanding publication under clinical sciences at AIIMS, New Delhi in 2022

• Delivered TILAK VENKOBA RAO ORATION held in Annual National Conference of Indian Psychiatric Society (ANCIPS), 2017

• Awarded CERTIFICATE OF COMMENDATION for paper titled “Pattern of Drug Use and Associated Behaviours among Female Injecting Drug Users from Northeast India: A Multi-Centric, Cross-Sectional, Comparative Study” at AIIMS, New Delhi in 2016

14. Other relevant information

• Regional Representative (South and Southeast Asia), International Society of Addiction Medicine

• Expert, Technical Resource Group (Injecting Drug Use), National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India

• Member, Subject Expert Committee (Neurology and Psychiatry), Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India

• Treasurer, Addiction Psychiatry Society of India

• Fellow, International Society of Addiction Medicine

• Fellow, Indian Psychiatric Society